Management of the Hepatic Lymph Nodes during Resection of Liver Metastases from Colorectal Cancer: A Systematic Review
Table 3
Survival in each category.
Category
Number of studies
Node-positive
Node-negative
Total number
Number survived
Total number
Number survived
Three-year survival
All studies
9
151
17 (11.3%)
787
424 (53.9%)
Studies including microscopic hepatic
node involvement
3
39
8 (20.5%)
193
109 (56.5%)
Studies where routine lymphadenectomy was performed irrespective
of the macroscopic nodal status
7
136
15 (11.0%)
696
365 (52.4%)
Studies which involved clearance of perihepatic nodes or hilar
nodes only
2
15
2 (13.3%)
91
59 (64.8%)
Studies which involved clearance of nodes
along the hepatoduodenal ligament only (as opposed to clearance of the
retropancreatic group, common hepatic artery group, and celiac group)
3
82
3 (4.7%)
348
160 (46.0%)
Studies which involved clearance of all the
groups of nodes in the hepatic pedicle
4
151
17 (11.3%)
787
424 (53.9%)
Studies in which chemotherapy was used
2
45
3 (6.7%)
132
62 (47.0%)
Studies published before 2000
7
111
9 (8.1%)
511
261 (51.1%)
Studies published after 2000
2
40
8 (20%)
276
163 (59.1%)
Five-year Survival
All studies
7
137
2 (1.5%)
767
246 (32.1%)
Studies including microscopic hepatic node involvement
2
31
1 (3.2%)
189
50 (26.5%)
Studies where routine lymphadenectomy was performed irrespective
of the macroscopic nodal status
6
130
2 (1.5%)
680
199 (29.3%)
Studies which involved clearance of perihepatic nodes or hilar
nodes only
1
7
0 (0%)
47
87 (54.0%)
Studies which involved clearance of nodes
along the hepatoduodenal ligament only (as opposed to clearance of the
retropancreatic group, common hepatic artery, group and celiac group)
3
82
1 (1.2%)
348
82 (23.6%)
Studies which involved clearance of all the
groups of nodes in the hepatic pedicle
